1 Gilenya Market Overview

• 1.1 Product Overview and Scope of Gilenya
• 1.2 Gilenya Segment by Type
  • 1.2.1 Global Gilenya Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 28 Capsules/Box
  • 1.2.3 96 Capsules/Box
• 1.3 Gilenya Segment by Application
  • 1.3.1 Gilenya Sales Comparison by Application: (2021-2027)
  • 1.3.2 Retail Pharmacy
  • 1.3.3 Hospital Pharmacy
  • 1.3.4 Other
• 1.4 Global Gilenya Market Size Estimates and Forecasts
  • 1.4.1 Global Gilenya Revenue 2016-2027
  • 1.4.2 Global Gilenya Sales 2016-2027
  • 1.4.3 Gilenya Market Size by Region: 2016 Versus 2021 Versus 2027

2 Gilenya Market Competition by Manufacturers

• 2.1 Global Gilenya Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Gilenya Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Gilenya Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Gilenya Manufacturing Sites, Area Served, Product Type
• 2.5 Gilenya Market Competitive Situation and Trends
  • 2.5.1 Gilenya Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Gilenya Players Market Share by Revenue
  • 2.5.3 Global Gilenya Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Gilenya Retrospective Market Scenario by Region

• 3.1 Global Gilenya Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.2 Global Gilenya Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.3 North America Gilenya Market Facts & Figures by Country
  • 3.3.1 North America Gilenya Sales by Country
  • 3.3.2 North America Gilenya Revenue by Country
  • 3.3.3 U.S.
  • 3.3.4 Canada
• 3.4 Europe Gilenya Market Facts & Figures by Country
  • 3.4.1 Europe Gilenya Sales by Country
  • 3.4.2 Europe Gilenya Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Gilenya Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Gilenya Sales by Region
  • 3.5.2 Asia Pacific Gilenya Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
  • 3.5.12 Philippines
  • 3.5.13 Vietnam
• 3.6 Latin America Gilenya Market Facts & Figures by Country
  • 3.6.1 Latin America Gilenya Sales by Country
  • 3.6.2 Latin America Gilenya Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Gilenya Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Gilenya Sales by Country
  • 3.7.2 Middle East and Africa Gilenya Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Gilenya Historic Market Analysis by Type

• 4.1 Global Gilenya Sales Market Share by Type (2016-2021)
• 4.2 Global Gilenya Revenue Market Share by Type (2016-2021)
• 4.3 Global Gilenya Price by Type (2016-2021)

5 Global Gilenya Historic Market Analysis by Application

• 5.1 Global Gilenya Sales Market Share by Application (2016-2021)
• 5.2 Global Gilenya Revenue Market Share by Application (2016-2021)
• 5.3 Global Gilenya Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Novartis
  • 6.1.1 Novartis Corporation Information
  • 6.1.2 Novartis Description and Business Overview
  • 6.1.3 Novartis Gilenya Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Novartis Product Portfolio
  • 6.1.5 Novartis Recent Developments/Updates

7 Gilenya Manufacturing Cost Analysis

• 7.1 Gilenya Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Gilenya
• 7.4 Gilenya Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Gilenya Distributors List
• 8.3 Gilenya Customers

9 Gilenya Market Dynamics

• 9.1 Gilenya Industry Trends
• 9.2 Gilenya Growth Drivers
• 9.3 Gilenya Market Challenges
• 9.4 Gilenya Market Restraints

10 Global Market Forecast

• 10.1 Gilenya Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Gilenya by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Gilenya by Type (2022-2027)
• 10.2 Gilenya Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Gilenya by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Gilenya by Application (2022-2027)
• 10.3 Gilenya Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Gilenya by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Gilenya by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
28 Capsules/Box
96 Capsules/Box

Segment by Application
Retail Pharmacy
Hospital Pharmacy
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Novartis